Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600 Life Science Investing
Precigen to Announce First Quarter 2026 Financial Results and Provide Business Updates on May 13 Life Science Investing
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in May Life Science Investing
Quantum-Si Reports First Quarter 2026 Financial Results and Highlights Proteus Development Milestones Life Science Investing
Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates Life Science Investing
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results Life Science Investing
Annexon Reports First Quarter 2026 Financial Results, Portfolio Progress and Key Anticipated Milestones Life Science Investing
AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE Life Science Investing
Arcturus Therapeutics Announces First Quarter 2026 Financial Results and Pipeline Progress Life Science Investing
BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â
